AltruMed develops DOVE, a discreet wearable device that detects early signs of opioid overdose and alerts nearby bystanders and emergency responders. Worn beneath clothing on the shoulder, the device uses noninvasive optical and motion sensors to monitor physiological changes associated with overdose. DOVE has received FDA Breakthrough Device designation and is being developed by a team spanning technology, medical, operations, and public-health expertise.
FDA Breakthrough Device Designation
Compliance program